IP Library Granted Patent US 11,111,530
Granted Patent B2
US 11,111,530 · App. 15/863,644 · Granted Sep 7, 2021

Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions

Inventors: Martin Beaulieu (San Diego, CA); Dirk Johannes Van Den Boom (La Jolla, CA)
Assignee: Agena Biosciences, Inc.
C12Q1/6858C12Q1/6844C12Q1/6872C12Q1/6874C12Q1/6886C12Q1/686C12Q2600/156C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,111,530
App. No.
15/863,644
Granted
Sep 7, 2021
Kind
B2
Abstract

Provided herein are optimized methods for performing multiplexed detection of a plurality of sequence variations. Also provided are methods for performing multiplexed amplification of target nucleic acid.

Claims (24)

1. A method for performing multiplexed amplification of target nucleic acid, comprising:

(a) forming a mixture containing 7 or more pairs of primary and secondary primers and one or more target nucleic acids, wherein each primer pair amplifies a nucleic acid-target region of a target nucleic acid and a sequence tag is attached to one or both of the primary and secondary primers of one or more primer pairs; and

(b) amplifying a plurality of nucleic acid-target regions of (a) under amplification conditions, whereby at least 60% of the 7 or more nucleic acid-target regions attempted are amplified by the 7 or more amplification primer pairs to produce an amplified mixture of nucleic acid-target regions, wherein the amplification conditions comprise a multiplicity of thermocycles and amplification reactants comprising a polymerase, dNTPs and MgCl 2 , wherein the ratio of the concentration of MgCl 2 to the concentration of each one of the dNTPs is less than or equal to 10:1 and only a single primer pair is used to amplify each particular nucleic acid target-region.

2. The method of claim 1 , wherein the concentration of each dNTP is between about 400-700 μM.

3. The method of claim 1 , wherein the free Mg 2+ concentration is between 1.0-2.0 mM.

4. The method of claim 1 , wherein the polymerase is Taq polymerase.

5. The method of claim 1 , wherein the amplification reaction conditions comprise about 100 nM primer pairs, and between about 2.6 up to about 4.8 mM MgCl 2 .

6. The method of claim 1 , wherein a sequence tag is attached to both primers of one or more primer pairs.

7. The method of claim 1 , further comprising inactivating one or more amplification reactants, wherein the one or more amplification reactants includes a nucleotide and/or a primer.

8. The method of claim 7 , wherein the amplification reactant that is a nucleotide is inactivated by a phosphatase and/or the amplification reactant that is a primer is inactivated by a nuclease.

9. The method of claim 8 , wherein the nuclease is an exonuclease.

10. The method of claim 1 , wherein for each amplification primer pair, one primer is in lower concentration than the other primer.

11. The method of claim 1 , wherein the ratio of the concentration of MgCl 2 to the concentration of each one of the dNTPs is less than or equal to 9:1.

12. The method of claim 1 , wherein the multiplicity of thermocycles is about 45.

13. The method of claim 1 , wherein the amplification conditions excludes the addition of one or more of BSA, glycerol, DMSO and urea.

14. The method of claim 4 , wherein the Taq polymerase is at a concentration of 0.03 units/μl.

15. The method of claim 1 , whereby at least 90% of the 7 or more nucleic acid-target regions attempted are amplified by the 7 or more amplification primer pairs.

16. The method of claim 1 , wherein the free Mg 2+ concentration is between about 1.3 to about 1.7 mM.

17. The method of claim 1 , wherein the ratio of the concentration of MgCl 2 to the concentration of each one of the dNTPs is less than or equal to 7:1.

18. The method of claim 1 , wherein the ratio of the concentration of MgCl 2 to the concentration of each one of the dNTPs is less than or equal to 6:1.

19. The method of claim 1 , wherein the mixture of (a) contains 13 or more pairs of primary and secondary primers, whereby at least 60% of the 13 or more nucleic acid-target regions attempted are amplified by the 13 or more amplification primer pairs.

20. The method of claim 1 , wherein a sequence tag is attached to all primers.

21. The method of claim 1 , wherein the sequence tag is from 5 up to 20 nucleotides in length.

22. The method of claim 1 , wherein the sequence tag comprises the sequence of nucleotides of SEQ ID NO: 37.

Assignments (4)
SECURITY INTEREST Recorded Dec 10, 2021
From: AGENA BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058358/0661 →
CHANGE OF NAME Recorded Mar 23, 2021
From: SEQUENOM, INC.
To: BIOSCIENCES ACQUISITION COMPANY
Reel/Frame 055687/0311 →
CHANGE OF NAME Recorded Mar 23, 2021
From: BIOSCIENCES ACQUISITION COMPANY
To: AGENA BIOSCIENCE, INC.
Reel/Frame 055693/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2018
From: VAN DEN BOOM, DIRK; BEAULIEU, MARTIN
To: AGENA BIOSCIENCE, INC.
Reel/Frame 045842/0171 →
Continuity (6)
Continuation 14720179 · May 22, 2015
Continuation 13718758 · Dec 18, 2012
Continuation 13193390 · Jul 28, 2011
Continuation 10903268 · Jul 30, 2004
Provisional Application 60492102 · Jul 31, 2003
Related Publication 20180245146A1 · Aug 30, 2018
Cited By (2)
US 12,454,722 US 12,630,865